Recommendation 12

As part of its 2019–24 National Action Plan for AMR, the third UK plan of its kind, the government set five domestic targets. These related to levels of drug-resistant and Gram-negative bloodstream infections (named after a bacteria-testing method and are more likely to be resistant to antimicrobials), use of antimicrobials in humans and animals, and use of diagnostic tests.29 However, only one of these five targets, relating to use of antimicrobials in animals, was achieved. NHS England told us that the 22 Qq 56–62 23 Q 62 24 Qq 60, 61 25 Q 16; C&AG’s Report, paras 2.7, 3.20 26 Q 43 27 House of Commons Library, US aid, the UK, and funding for multilateral aid bodies in 2025, 18 March 2025 28 AR0007, AR0009, AR0015, AR0021, AR0025 29 C&AG’s Report, paras 8, 2.11 and 2.14 11 targets were not achieved as they were overambitious, and the targets had been based on previous success with other targeted infections such as MRSA, which involve a different mode of transmission, as well as the impact of the pandemic such as a post-pandemic resurgence of infections. NHS England believes that progress was still made even though the targets were not hit.30